Survival of patients with thyroid papillary and follicular carcinoma: similarity and difference of prognostic factors (cohort retrospective study).

Authors

  • Bogdan Guda State Institution “V. P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine” Vyshgorodska str., 69, Kyiv, Ukraine, 04114, Ukraine

DOI:

https://doi.org/10.15587/2519-4798.2019.174444

Keywords:

papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), prognostic factors, МАСIS

Abstract

While analyzing the causes supposed to be important for disease prognosis and to impact on the patient’s survival of malignant thyroid tumors, the researches examine many factors. The aim of the study was to determine the indices of cumulative patients survival with differentiated thyroid carcinoma that belong to different histological types depending on biological properties of neoplasm and some clinical factors.

Materials and methods: Retrospective study of the cohort of patients after surgical intervention. The information of patients (age and sex, histological type, size and categories of carcinomas (TNM), their invasive properties, the presence of multifocal growth), as well as the clinical characteristics of the disease (stage, volume of surgical intervention and radioiodine treatment, risk of relapse group, number of points in the system MACIS) was analysed.

Results: In cases of papillary or follicular thyroid carcinoma the analyzed factors are important for further prognosis. The most essential factor for papillary carcinoma is the tumor size, which associated with other ones – metastasizing, multifocal growth, intra- and extra-thyroid invasion, relapse development. In patients below 45, which were operated because of cancer, without extra-thyroid tumor spreading and metastases, the favorable disease prognosis does not depend on the neoplasm type. Under other circumstances the impact of carcinoma histological type (for follicular carcinoma versus papillary ones) is more important, and in some cases – for men, for patients above 60, patients with tumors above40 mm, for multifocal neoplasm with intra- and especially extra-thyroid invasion, for cases of distant metastases, thyroidectomy with lymph nodes dissection, with relapses the histological tumor type, is extremely important.

Conclusion: The obtained results confirm the conclusion that histological subtype of differentiated thyroid carcinoma, tumor size, age and patient gender are the most important predictor of diseases persistence/disease relapse or patients mortality

Author Biography

Bogdan Guda, State Institution “V. P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine” Vyshgorodska str., 69, Kyiv, Ukraine, 04114

PhD, Senior Researcher

Department of Surgical

References

  1. Glikson, E., Alon, E., Bedrin, L., Talmi, Y. (2017). Prognostic factors in differentiated thyroid cancer revisited. Israel Medical Association Journal, 19 (2), 114–118.
  2. Konturek, A., Barczyński, M., Nowak, W., Richter, P. (2012). Prognostic factors in differentiated thyroid cancer – a 20-year surgical outcome study. Langenbeck’s Archives of Surgery, 397 (5), 809–815. doi: http://doi.org/10.1007/s00423-011-0899-z
  3. Passler, C., Scheuba, C., Prager, G., Kaczirek, K., Kaserer, K., Zettinig, G., Niederle, B. (2004). Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocrine-Related Cancer, 11, 131–139. doi: http://doi.org/10.1677/erc.0.0110131
  4. Gulcelik, M. A., Ozdemir, Y., Kadri Colakoglu, M., Camlibel, M., Alagol, H. (2012). Prognostic factors determining survival in patients with node positive differentiated thyroid cancer: a retrospective cross-sectional study. Clinical Otolaryngology, 37 (6), 460–467. doi: http://doi.org/10.1111/coa.12022
  5. Lorea, A. E., Bermejo, I. M., Esparza, N. E., Apinaniz, E. A., Arribas, J. P., Echarri, A. I. et. al. (2018). Clinical characteristics and prognostic factors in patients with follicular thyroid carcinoma. Endocrine Abstracts, 56, 1143. doi: http://doi.org/10.1530/endoabs.56.p1146
  6. Lang, B. H.-H., Lo, C.-Y., Chan, W.-F., Lam, K.-Y., Wan, K.-Y. (2006). Prognostic Factors in Papillary and Follicular Thyroid Carcinoma: Their Implications for Cancer Staging. Annals of Surgical Oncology, 14 (2), 730–738. doi: http://doi.org/10.1245/s10434-006-9207-5
  7. Sautter-Bihl, M.-L., Raub, J., Hetzel-Sesterheim, M., Heinze, H. G. (2001). Differentiated Thyroid Cancer: Prognostic Factors and Influence of Treatment on the Outcome in 441 Patients. Strahlentherapie Und Onkologie, 177 (3), 125–131. doi: http://doi.org/10.1007/pl00002392
  8. Nitipir, C., Alecu, L., Slavu, I., Tulin, R., Jecan, R., Orlov, C. et. al. (2018). Unmodifiable variables related to thyroid cancer incidence. Journal of Mind and Medical Sciences, 5 (1), 123–128. doi: http://doi.org/10.22543/7674.51.p123128
  9. Tang, J., Liu, H. B., Yu, L., Meng, X., Leng, S. X., Zhang, H. (2018). Clinical-pathological Characteristics and Prognostic Factors for Papillary Thyroid Microcarcinoma in the Elderly. Journal of Cancer, 9 (2), 256–262. doi: http://doi.org/10.7150/jca.22700
  10. Kauffmann, R. M., Hamner, J. B., Ituarte, P. H. G., Yim, J. H. (2018). Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging? BMC Cancer, 18 (1). doi: http://doi.org/10.1186/s12885-018-4181-4
  11. Santrac, N., Markovic, I., Goran, M., Buta, M., Djurisic, I., Dzodic, R. (2017). Prognostic factors for intrathyroidal papillary carcinomas – a multivariate analysis. Endocrine Abstracts, 49. doi: http://doi.org/10.1530/endoabs.49.gp225
  12. O’Neill, C. J., Vaughan, L., Learoyd, D. L., Sidhu, S. B., Delbridge, L. W., Sywak, M. S. (2011). Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. European Journal of Surgical Oncology, 37 (2), 181–185. doi: http://doi.org/10.1016/j.ejso.2010.11.005
  13. Azhar, Y., Achmad, D., Lukman, K., Hilmanto, D. (2018). Pediatric differentiated thyroid carcinoma risk factor for analysis for disease free survival. Indian Journal of Medical and Paediatric Oncology, 39 (2), 153–158. doi: http://doi.org/10.4103/ijmpo.ijmpo_70_17
  14. Ito, Y., Miyauchi, A., Kihara, M., Fukushima, M., Higashiyama, T., Miya, A. (2018). Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients. World Journal of Surgery, 42 (3), 615–622. doi: http://doi.org/10.1007/s00268-018-4479-z
  15. Barbaro, D., Simi, U., Meucci, G., Lapi, P., Orsini, P., Pasquini, C. (2005). Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and non-incidental cancers – are they different diseases? Clinical Endocrinology, 63 (5), 577–581. doi: http://doi.org/10.1111/j.1365-2265.2005.02386.x
  16. Gomez, N. R., Kouniavsky, G., Tsai, H.-L., Somervell, H., Pai, S. I., Tufano, R. P. et. al. (2011). Tumor size and presence of calcifications on ultrasonography are pre-operative predictors of lymph node metastases in patients with papillary thyroid cancer. Journal of Surgical Oncology, 104 (6), 613–616. doi: http://doi.org/10.1002/jso.21891
  17. Qu, N., Shi, R., Yang, S., Ma, B., Lu, Z., Wen, D. et. al. (2016). Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model. OncoTargets and Therapy, 9, 5015–5022. doi: http://doi.org/10.2147/ott.s107187
  18. Gong, Y., Li, G., Lei, J., You, J., Jiang, K., Li, Z. et. al. (2018). A favorable tumor size to define papillary thyroid microcarcinoma: an analysis of 1176 consecutive cases. Cancer Management and Research, 10, 899–906. doi: http://doi.org/10.2147/cmar.s154135
  19. Gillanders, S. L., O’Neill, J. P. (2018). Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC). European Journal of Surgical Oncology, 44 (3), 286–296. doi: http://doi.org/10.1016/j.ejso.2017.07.013
  20. Wu, M.-H., Shen, W. T., Gosnell, J., Duh, Q.-Y. (2014). Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer. Head & Neck, 37 (9), 1336–1343. doi: http://doi.org/10.1002/hed.23747
  21. Lango, M., Flieder, D., Arrangoiz, R., Veloski, C., Yu, J. Q., Li, T. et. al. (2013). Extranodal Extension of Metastatic Papillary Thyroid Carcinoma: Correlation with Biochemical Endpoints, Nodal Persistence, and Systemic Disease Progression. Thyroid, 23 (9), 1099–1105. doi: http://doi.org/10.1089/thy.2013.0027
  22. Lamartina, L., Grani, G., Durante, C., Filetti, S. (2018). Recent advances in managing differentiated thyroid cancer. F1000Research, 7, 86. doi: http://doi.org/10.12688/f1000research.12811.1
  23. Wang, L. Y., Palmer, F. L., Nixon, I. J., Thomas, D., Patel, S. G., Shaha, A. R. et. al. (2014). Multi-Organ Distant Metastases Confer Worse Disease-Specific Survival in Differentiated Thyroid Cancer. Thyroid, 24 (11), 1594–1599. doi: http://doi.org/10.1089/thy.2014.0173
  24. Lee, J., Soh, E.-Y. (2010). Differentiated Thyroid Carcinoma Presenting With Distant Metastasis at Initial Diagnosis. Annals of Surgery, 251 (1), 114–119. doi: http://doi.org/10.1097/sla.0b013e3181b7faf6
  25. Sugitani, I., Fujimoto, Y., Yamamoto, N. (2008). Papillary thyroid carcinoma with distant metastases: Survival predictors and the importance of local control. Surgery, 143 (1), 35–42. doi: http://doi.org/10.1016/j.surg.2007.06.011
  26. Wreesmann, V. B., Nixon, I. J., Rivera, M., Katabi, N., Palmer, F., Ganly, I. et. al. (2015). Prognostic Value of Vascular Invasion in Well-Differentiated Papillary Thyroid Carcinoma. Thyroid, 25 (5), 503–508. doi: http://doi.org/10.1089/thy.2015.0052
  27. Hotomi, M., Sugitani, I., Toda, K., Kawabata, K., Fujimoto, Y. (2012). A Novel Definition of Extrathyroidal Invasion for Patients with Papillary Thyroid Carcinoma for Predicting Prognosis. World Journal of Surgery, 36 (6), 1231–1240. doi: http://doi.org/10.1007/s00268-012-1518-z
  28. Yu, X.-M., Lo, C.-Y., Lam, A. K.-Y., Leung, P., Luk, J. M. (2008). Serum Vascular Endothelial Growth Factor C Correlates With Lymph Node Metastases and High-Risk Tumor Profiles in Papillary Thyroid Carcinoma. Annals of Surgery, 247 (3), 483–489. doi: http://doi.org/10.1097/sla.0b013e31815fa447
  29. Tam, A. A., Özdemir, D., Çuhacı, N., Başer, H., Aydın, C., Yazgan, A. K. Et. al. (2016). Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer. Endocrine, 53 (3), 774–783. doi: http://doi.org/10.1007/s12020-016-0955-0
  30. Lang, B. H.-H., Wong, K. P., Cheung, C. Y., Wan, K. Y., Lo, C.-Y. (2012). Evaluating the Prognostic Factors Associated with Cancer-specific Survival of Differentiated Thyroid Carcinoma Presenting with Distant Metastasis. Annals of Surgical Oncology, 20 (4), 1329–1335. doi: http://doi.org/10.1245/s10434-012-2711-x

Downloads

Published

2019-08-02

How to Cite

Guda, B. (2019). Survival of patients with thyroid papillary and follicular carcinoma: similarity and difference of prognostic factors (cohort retrospective study). ScienceRise: Medical Science, (4 (31), 15–23. https://doi.org/10.15587/2519-4798.2019.174444

Issue

No. 4 (31) (2019)

Section

Medical Science

License

Copyright (c) 2019 Huda Bogdan

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.